Literature DB >> 8625301

A truncated hMSH2 transcript occurs as a common variant in the population: implications for genetic diagnosis.

L Xia1, W Shen, F Ritacca, A Mitri, L Madlensky, T Berk, Z Cohen, S Gallinger, B Bapat.   

Abstract

Germline mutations of the hMSH2 gene are responsible for many cases of hereditary nonpolyposis colorectal cancer. While screening for hMSH2 gene mutations in hereditary nonpolyposis colorectal cancer kindreds, we observed that a previously reported germline mutation is in fact a common, alternatively spliced variant in the population. Using RT-PCR and the protein truncation test, the hMSH2 exon 13 deletion variant was found in more than 90% of individuals. The exon 13 deletion transcript was only present in lymphocyte RNA, no abnormalities were detected in genomic DNA flanking exon 13, and the deletion transcript is apparently not translated. These findings highlight further that caution should be exercised in providing genetic risk assessment on the basis of currently used germline mutation detection strategies.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8625301

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  6 in total

1.  Association between the hMSH2 IVS12-6 T>C polymorphism and cancer risk: A meta-analysis.

Authors:  Song Wu; Jingyu Chen; Yong Ji; Yuxin Liu; Lu Gao; Guoqiang Chen; Kai Shen; Bin Huang
Journal:  Exp Ther Med       Date:  2011-08-16       Impact factor: 2.447

2.  Reduction in hMSH2 mRNA levels by premature translation termination: implications for mutation screening in hereditary nonpolyposis colorectal cancer.

Authors:  X Lin; J H Choi; P Lynch; L Xi; E Wu; M L Frazier
Journal:  Dig Dis Sci       Date:  1999-03       Impact factor: 3.199

3.  A polymorphism within the mismatch repair gene predicts prognosis and adjuvant chemotherapy benefit in gastric cancer.

Authors:  Xiaohui Zhao; Dongfang Dai; Xiaoqin Li; Bo Shen; Xiaofeng Chen; Yongqian Shu; Deqiang Wang
Journal:  Gastric Cancer       Date:  2019-04-15       Impact factor: 7.370

4.  An intronic mutation in MLH1 associated with familial colon and breast cancer.

Authors:  F Bianchi; M Raponi; F Piva; A Viel; I Bearzi; E Galizia; R Bracci; L Belvederesi; C Loretelli; C Brugiati; F Corradini; D Baralle; R Cellerino
Journal:  Fam Cancer       Date:  2011-03       Impact factor: 2.375

5.  Extensive molecular screening for hereditary non-polyposis colorectal cancer.

Authors:  B Dieumegard; S Grandjouan; J C Sabourin; M L Le Bihan; I Lefrère; J P Pignon; P Rougier; P Lasser; J Bénard; D Couturier; B Bressac-de Paillerets
Journal:  Br J Cancer       Date:  2000-02       Impact factor: 7.640

6.  Intron splice acceptor site polymorphism in the hMSH2 gene in sporadic and familial colorectal cancer.

Authors:  M Palicio; I Blanco; S Tórtola; I González; E Marcuello; J Brunet; F Lluis; J J González-Aguilera; M A Peinado; G Capella
Journal:  Br J Cancer       Date:  2000-02       Impact factor: 7.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.